Expanding our manufacturing capabilities is an important step in our mission to make high-quality medicines more affordable and accessible to patients around the world. 🌍💊
We are proud to announce the completion of our Production Block 1 expansion at our state-of-the-art facilities in Hyderabad, India.🎉 The new facility marks an important milestone in the continued development of our manufacturing and warehouse capacities.📈
The expansion will:
🔹 Add approximately 600 million oral solid dosage units – including tablets and capsules to our annual production capacity💊📦
🔹 Integrate advanced European manufacturing and packaging technologies to enable smarter, more automated and highly efficient operations⚙️
🔹 Increase our warehouse capacities for APIs and finished dosage forms🏗️📦
This investment strengthens our ability to respond to the growing demand for high-quality medicines while advancing operational excellence, innovation, and sustainable growth.🌱
More than an expansion of our facilities, this is an investment in the future of healthcare – and in our ability to support patients worldwide with greater scale, reliability and ambition.💙🌍
Watch the video and see how the construction progressed over the last year. ➡️
